These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 35089264)

  • 1. Axillary or Subclavian Impella 5.0 Support in Cardiogenic Shock: A Systematic Review and Meta-analysis.
    Schultz J; Duval S; Shaffer A; John R; Alexy T; Martin CM; Cogswell R
    ASAIO J; 2022 Feb; 68(2):233-238. PubMed ID: 35089264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of the axillary Impella 5.0 device on patients with acute cardiogenic shock.
    Tarabichi S; Ikegami H; Russo MJ; Lee LY; Lemaire A
    J Cardiothorac Surg; 2020 Aug; 15(1):218. PubMed ID: 32795321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impella 5.0 Support in INTERMACS II Cardiogenic Shock Patients Using Right and Left Axillary Artery Access.
    Schibilsky D; Lausberg H; Haller C; Lenglinger M; Woernle B; Haeberle H; Rosenberger P; Walker T; Schlensak C
    Artif Organs; 2015 Aug; 39(8):660-3. PubMed ID: 26147682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term mechanical circulatory support with the Impella 5.0 device for cardiogenic shock at La Pitié-Salpêtrière.
    Mastroianni C; Bouabdallaoui N; Leprince P; Lebreton G
    Eur Heart J Acute Cardiovasc Care; 2017 Feb; 6(1):87-92. PubMed ID: 26873912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impella in cardiogenic shock following acute myocardial infarction: a systematic review and meta-analysis.
    Vargas KG; Jäger B; Kaufmann CC; Biagioli A; Watremez S; Gatto F; Özbek C; Razouk A; Geppert A; Huber K
    Wien Klin Wochenschr; 2020 Dec; 132(23-24):716-725. PubMed ID: 32691215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of Impella 5.0 in Cardiogenic Shock: A Systematic Review and Meta-analysis.
    Batsides G; Massaro J; Cheung A; Soltesz E; Ramzy D; Anderson MB
    Innovations (Phila); 2018; 13(4):254-260. PubMed ID: 30142110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impella Support for Acute Myocardial Infarction Complicated by Cardiogenic Shock.
    Schrage B; Ibrahim K; Loehn T; Werner N; Sinning JM; Pappalardo F; Pieri M; Skurk C; Lauten A; Landmesser U; Westenfeld R; Horn P; Pauschinger M; Eckner D; Twerenbold R; Nordbeck P; Salinger T; Abel P; Empen K; Busch MC; Felix SB; Sieweke JT; Møller JE; Pareek N; Hill J; MacCarthy P; Bergmann MW; Henriques JPS; Möbius-Winkler S; Schulze PC; Ouarrak T; Zeymer U; Schneider S; Blankenberg S; Thiele H; Schäfer A; Westermann D
    Circulation; 2019 Mar; 139(10):1249-1258. PubMed ID: 30586755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short term outcomes of Impella in cardiogenic shock: A review and meta-analysis of observational studies.
    Iannaccone M; Albani S; Giannini F; Colangelo S; Boccuzzi GG; Garbo R; Brilakis ES; D'ascenzo F; de Ferrari GM; Colombo A
    Int J Cardiol; 2021 Feb; 324():44-51. PubMed ID: 32971148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous left-ventricular support with the Impella-2.5-assist device in acute cardiogenic shock: results of the Impella-EUROSHOCK-registry.
    Lauten A; Engström AE; Jung C; Empen K; Erne P; Cook S; Windecker S; Bergmann MW; Klingenberg R; Lüscher TF; Haude M; Rulands D; Butter C; Ullman B; Hellgren L; Modena MG; Pedrazzini G; Henriques JP; Figulla HR; Ferrari M
    Circ Heart Fail; 2013 Jan; 6(1):23-30. PubMed ID: 23212552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanical circulatory support with Impella versus intra-aortic balloon pump or medical treatment in cardiogenic shock-a critical appraisal of current data.
    Wernly B; Seelmaier C; Leistner D; Stähli BE; Pretsch I; Lichtenauer M; Jung C; Hoppe UC; Landmesser U; Thiele H; Lauten A
    Clin Res Cardiol; 2019 Nov; 108(11):1249-1257. PubMed ID: 30900010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanical circulatory support with the Impella® LP5.0 pump and an intra-aortic balloon pump for cardiogenic shock in acute myocardial infarction: The IMPELLA-STIC randomized study.
    Bochaton T; Huot L; Elbaz M; Delmas C; Aissaoui N; Farhat F; Mewton N; Bonnefoy E;
    Arch Cardiovasc Dis; 2020 Apr; 113(4):237-243. PubMed ID: 31740272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of Hemodynamic Support With Impella for Acute Myocardial Infarction Complicated by Cardiogenic Shock at a Rural Community Hospital Without On-Site Surgical Back-up.
    Wilkins CE; Herrera TL; Nagahiro MK; Weathers LB; Girotra SV; Sandhu F
    J Invasive Cardiol; 2019 Feb; 31(2):E23-E29. PubMed ID: 30700627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management and outcome of patients supported with Impella 5.0 for refractory cardiogenic shock.
    Gaudard P; Mourad M; Eliet J; Zeroual N; Culas G; Rouvière P; Albat B; Colson P
    Crit Care; 2015 Oct; 19():363. PubMed ID: 26453047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Axillary Artery Access for Mechanical Circulatory Support Devices in Patients With Prohibitive Peripheral Arterial Disease Presenting With Cardiogenic Shock.
    Kaki A; Blank N; Alraies MC; Jani A; Shemesh A; Kajy M; Laktineh A; Hasan R; Gade CLF; Mohamad T; Elder M; Schreiber T
    Am J Cardiol; 2019 May; 123(10):1715-1721. PubMed ID: 30879608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of mechanical circulatory support with Impella or intra-aortic balloon pump for high-risk percutaneous coronary intervention and/or cardiogenic shock: Insights from a network meta-analysis of randomized trials.
    Kuno T; Takagi H; Ando T; Kodaira M; Numasawa Y; Fox J; Bangalore S
    Catheter Cardiovasc Interv; 2021 Apr; 97(5):E636-E645. PubMed ID: 32894797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute Biventricular Mechanical Circulatory Support for Cardiogenic Shock.
    Kuchibhotla S; Esposito ML; Breton C; Pedicini R; Mullin A; O'Kelly R; Anderson M; Morris DL; Batsides G; Ramzy D; Grise M; Pham DT; Kapur NK
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29054842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous Venoarterial Extracorporeal Membrane Oxygenation and Percutaneous Left Ventricular Decompression Therapy with Impella Is Associated with Improved Outcomes in Refractory Cardiogenic Shock.
    Patel SM; Lipinski J; Al-Kindi SG; Patel T; Saric P; Li J; Nadeem F; Ladas T; Alaiti A; Phillips A; Medalion B; Deo S; Elgudin Y; Costa MA; Osman MN; Attizzani GF; Oliveira GH; Sareyyupoglu B; Bezerra HG
    ASAIO J; 2019 Jan; 65(1):21-28. PubMed ID: 29489461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maximum level of mobility with axillary deployment of the Impella 5.0 is associated with improved survival.
    Esposito ML; Jablonski J; Kras A; Krasney S; Kapur NK
    Int J Artif Organs; 2018 Apr; 41(4):236-239. PubMed ID: 29637832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impella versus extracorporal life support in cardiogenic shock: a propensity score adjusted analysis.
    Wernly B; Karami M; Engström AE; Windecker S; Hunziker L; Lüscher TF; Henriques JP; Ferrari MW; Binnebößel S; Masyuk M; Niederseer D; Abel P; Fuernau G; Franz M; Kelm M; Busch MC; Felix SB; Thiele H; Lauten A; Jung C
    ESC Heart Fail; 2021 Apr; 8(2):953-961. PubMed ID: 33560591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of the impella device for acute mechanical circulatory support.
    Lemaire A; Anderson MB; Prendergast T; Stockmaster N; Goodman A; Lozane AM; Batsides G
    Innovations (Phila); 2013; 8(1):12-6. PubMed ID: 23571788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.